Skip to main content

Table 1 Clinical characteristics in subjects with and without MetS

From: The association between adiponectin, HDL-cholesterol and α1-antitrypsin-LDL in female subjects without metabolic syndrome

Variable

Non-MetS

(n = 108)

MetS

(n = 86)

P value

Age, years

54.1 ± 9.6

53.4 ± 9.5

0.618

Current smoking, %

9.3

10.5

0.779

Body mass index, kg/m2

26.0 ± 2.5

27.5 ± 1.7

<0.0001**

Systolic blood pressure, mmHg

130 ± 17

146 ± 17

<0.0001**

Diastolic blood pressure, mmHg

79 ± 11

87 ± 10

<0.0001**

Fasting plasma glucose, mmol/L

5.85 ± 2.30

7.42 ± 3.10

<0.0001**

LDL-cholesterol, mmol/L

3.32 ± 0.80

3.38 ± 0.77

0.628

Triglyceride, mmol/L

1.15 (0.88-1.47)

1.88 (1.36-2.47)

<0.0001**

HDL-cholesterol, mmol/L

1.71 ± 0.33

1.48 ± 0.38

<0.0001**

Adiponectin, μg/mL

8.95 (5.53-12.2)

7.80 (4.80-10.9)

0.050*

AT-LDL, μg/mL

3.27 ± 1.02

3.00 ± 0.98

0.071

  1. MetS: metabolic syndrome, LDL: low-density lipoprotein, HDL: high-density lipoprotein, α1-AT-LDL: α1-antitrypsin-low-density lipoprotein. Data are expressed as the mean ± standard deviation, the median (interquartile range) or the percentage in each subject group. Significance level (subjects without MetS vs. those with MetS; unpaired t-test [triglyceride and adiponectin were log-transformed] or χ2 test): * P ≤ 0.05, ** P ≤ 0.01.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X